The anti-COVID-19 drug nirmatrelvir crosses the blood‒brain barrier and exhibits herb–drug pharmacokinetic interactions with Scutellaria baicalensis formulations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The anti-COVID-19 drug nirmatrelvir crosses the blood‒brain barrier and exhibits herb–drug pharmacokinetic interactions with Scutellaria baicalensis formulations

Published:2024-08 Issue:15 Volume:10 Page:e34820
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Lee Wan-Hsin,Kung Yen-Ying,Sun Chung-Kai,Chang Chun-Hao,Peng Wen-Ya^ORCID,Lin Lie-Chwen^ORCID,Hsu Chung-Hua^ORCID,Yang Muh-Hwa,Tsai Tung-Hu^ORCID

Funder

National Science and Technology Council

College of Medicine, National Taiwan University

Advanced Research Center for Green Materials Science and Technology, National Taiwan University

Publisher

Elsevier BV

Reference29 articles.

1. Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS-441524 in pregnant rats;Yang;EBioMedicine,2022

2. Transfer and biotransformation of the COVID-19 prodrug molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-placenta barrier;Chang;EBioMedicine,2023

3. Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101;Chang;J. Pharm. Biomed. Anal.,2023

4. The anti-COVID-19 drug Paxlovid crosses biological barriers of the placenta and brain in rats;Lee;npj Viruses,2024

5. Traditional Chinese medicine for COVID-19 treatment;Ren;Pharmacol. Res.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP